Recently, multi-omics analyses from both CDX and PDX of human SCLCs highlighted the genomic landscape of three SCLC subtypes driven by ASCL1, NEUROD1, and POU2F3 [177]. This evidence concerns the gene NEUROD1 and small cell lung carcinoma.